RUSSIAN TRANSLATION] ADDITIONAL AGREEMENT No. 2 to the Development, License and Supply Agreement dated August 1st, 2013 Moscow ____ ,2016

[RUSSIAN TRANSLATION]	ADDITIONAL AGREEMENT No. 2 to the Development, License and Supply Agreement dated August 1st, 2013
	Moscow ____ ,2016
	Joint Stock Company R-Pharm, represented by its General Director lgnatiev V .G., acting on the basis of the Chapter, hereinafter referred to as the "R-Pharm" on the one hand, and
	Scynexis, Inc., a corporation organized and existing under the laws of the State of Delaware, having offices located at 000 Xxxxxx Xxxxxx, Xxxxx 0000, Xxxxxx Xxxx, Xxx Xxxxxx, XXX 07302, hereinafter referred to as the "Scynexis" on the other hand,
	jointly are referred to as the "Parties",
	enter into the present Additional Agreement to the Development, License and Supply Agreement dated August 1st, 2013 executed by the Parties (hereinafter - "the Agreement" in accordance with the following:
	1. Due to the new bank details of Scynexis hereby the Parties agree to set forth the information about the bank details of Scynexis stipulated in the clause 15.18 of the Agreement shall be modified to read as follows: Scynexis, Inc. Account name: Name of Bank: Address of Bank: ABA Number
	2. Due to the relocation of Scynexis, the notice address for Scynexis under Section 5.ll(a) for adverse drug experiences shall be modified to read as follows: SCYNEXIS, Inc. 000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxx Xxxx, XX 00000 XXX E-mail: Facsimile No.: 000-000-0000 Telephone No.:
	3. Due to the relocation of Scynexis, the notice address for Scynexis under Section 15.5, for notices given under the Agreement, shall be modified to read as follows: SCYNEXIS, Inc. 000 Xxxxxx Xxxxxx, Xxxxx 0000 Xxxxxx Xxxx, XX 00000 XXX Attention: General Counsel Facsimile No.: x0-000-000-0000
	4.  The present Additional Agreement shall be the integral part of the Agreement and shall be valid from the date of signatures of the authorized representatives of the Parties.
	5. In everything that is not under discussion in the present Additional Agreement the provisions of the Agreement shall apply.
	6.  The present Additional Agreement has been executed in two equal counterparts, one for each Party.
	7.  In case of any discrepancies between the English and Russian texts of the present Additional Agreement, the English version shall be applied.

SIGNATURES OF THE PARTIES:

“R-Pharm”, JSC

By: /s/ R-Pharm, JSC

Name:

Title:

Scynexis, Inc.

By: /s/ Xxxx Xxxxxxxx

Name: Xxxx Xxxxxxxx

Title: CFO